Location: New York, NY
CIK: 0001482416 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 16, 2021
Total Value: $402M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| ASND | ASCENDIS PHARMA A/S | 251,900 | $33.14M | 8.2% | $131.55 | — | — | Put | 04351P101 |
| — | CURIS INC | 3,364,405 | $27.15M | 6.7% | $8.07 | $1.20 | — | COM NEW | 231269200 |
| CI | CIGNA CORP | 87,192 | $20.67M | 5.1% | $237.07 * | $179.06 | +28.3% | COM | 125523100 |
| — | SOLITON INC | 824,803 | $18.55M | 4.6% | $22.49 | $7.78 | — | COM | 834251100 |
| GLD | SPDR GOLD SHARES | 95,430 | $15.81M | 3.9% | $165.63 | $158.19 | — | GOLD SHS | 78463V107 |
| AVAH | AVEANNA HEALTHCARE HOLDINGS INC | 1,201,607 | $14.86M | 3.7% | $12.37 * | $11.86 | 0.0% | COM | 05356F105 |
| HCA | HCA HEALTHCARE INC | 65,573 | $13.56M | 3.4% | $206.75 * | $111.08 | +76.2% | COM | 40412C101 |
| CNC | CENTENE CORP | 155,616 | $11.35M | 2.8% | $72.93 * | $61.92 | +10.6% | COM | 15135B101 |
| UHS | UNIVERSAL HEALTH SERVICES INC | 73,135 | $10.71M | 2.7% | $146.43 | $122.99 | +20.0% | CL B | 913903100 |
| MCK | MCKESSON CORP | 49,624 | $9.49M | 2.4% | $191.24 | $150.14 | +25.3% | COM | 58155Q103 |
| — | ALBIREO PHARMA INC | 265,616 | $9.344M | 2.3% | $35.18 | $33.37 | — | COM | 01345P106 |
| — | HILL-ROM HOLDINGS INC | 76,647 | $8.706M | 2.2% | $113.59 | $95.34 | — | COM | 431475102 |
| AMGN | AMGEN INC | 35,000 | $8.531M | 2.1% | $243.74 * | $212.50 | 0.0% | COM | 031162100 |
| UTHR | UNITED THERAPEUTICS CORP | 46,712 | $8.381M | 2.1% | $179.42 * | $118.46 | +60.8% | COM | 91307C102 |
| HLF | HERBALIFE NUTRITION LTD | 154,838 | $8.165M | 2.0% | $52.73 * | $49.22 | +1.0% | COM SHS | G4412G101 |
| MIRM | MIRUM PHARMACEUTICALS INC | 454,892 | $7.865M | 2.0% | $17.29 * | $19.59 | -8.5% | COM | 604749101 |
| — | SPRUCE BIOSCIENCES INC | 647,239 | $7.256M | 1.8% | $11.21 | $22.64 | — | COM | 85209E109 |
| — | HORIZON THERAPEUTICS PLC | 67,471 | $6.318M | 1.6% | $93.64 | $78.31 | — | SHS | G46188101 |
| ITGR | INTEGER HOLDINGS CORP | 66,828 | $6.295M | 1.6% | $94.20 * | $92.12 | 0.0% | COM | 45826H109 |
| — | AFFIMED NV | 714,576 | $6.074M | 1.5% | $8.50 | $8.05 | — | COM | N01045108 |
| CHRS | COHERUS BIOSCIENCES INC | 413,733 | $5.722M | 1.4% | $13.83 * | $18.76 | -24.5% | COM | 19249H103 |
| — | SYNEOS HEALTH INC | 62,598 | $5.602M | 1.4% | $89.49 | $54.65 | — | CL A | 87166B102 |
| — | AYALA PHARMACEUTICALS INC | 542,977 | $5.533M | 1.4% | $10.19 | $10.72 | — | COM | 05465V108 |
| — | X4 PHARMACEUTICALS INC | 804,597 | $5.23M | 1.3% | $6.50 | $8.61 | — | COM | 98420X103 |
| HQY | HEALTHEQUITY INC | 64,958 | $5.228M | 1.3% | $80.48 * | $76.19 | 0.0% | COM | 42226A107 |
| — | ASLAN PHARMACEUTICALS LTD | 1,488,508 | $4.912M | 1.2% | $3.30 | $1.92 | — | ADS | 04522R101 |
| VRTX | VERTEX PHARMACEUTICALS INC | 23,900 | $4.819M | 1.2% | $201.63 * | $227.04 | -7.9% | COM | 92532F100 |
| KURA | KURA ONCOLOGY INC | 222,263 | $4.634M | 1.2% | $20.85 * | $30.54 | -18.7% | COM | 50127T109 |
| CCRN | CROSS COUNTRY HEALTHCARE INC | 279,850 | $4.62M | 1.1% | $16.51 * | $6.65 | +129.6% | COM | 227483104 |
| — | RADIUS HEALTH INC | 240,957 | $4.395M | 1.1% | $18.24 | $13.38 | — | COM NEW | 750469207 |
| — | CHARDAN HEALTHCARE ACQUISITION 2 CORP | 400,000 | $4.368M | 1.1% | $10.92 | $10.92 | — | UNIT | 15957T206 |
| — | SYROS PHARMACEUTICALS INC | 800,000 | $4.36M | 1.1% | $5.45 | $5.45 | — | COM | 87184Q107 |
| — | INARI MEDICAL INC | 46,332 | $4.322M | 1.1% | $93.28 | $93.28 | — | COM | 45332Y109 |
| — | ESSA PHARMA INC | 148,127 | $4.232M | 1.1% | $28.57 | $6.90 | — | COM NEW | 29668H708 |
| — | NEUBASE THERAPEUTICS INC | 868,699 | $4.161M | 1.0% | $4.79 | $6.27 | — | COM | 64132K102 |
| ARDX | ARDELYX INC | 525,996 | $3.987M | 1.0% | $7.58 * | $6.10 | +21.3% | COM | 039697107 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 591,870 | $3.93M | 1.0% | $6.64 | $6.64 | — | SPON ADS | 05280R100 |
| VKTX | VIKING THERAPEUTICS INC | 619,780 | $3.712M | 0.9% | $5.99 | $8.50 | -30.2% | COM | 92686J106 |
| — | MOLECULIN BIOTECH INC | 1,004,845 | $3.688M | 0.9% | $3.67 | $4.06 | — | COM | 60855D200 |
| — | PRECISION BIOSCIENCES INC | 293,440 | $3.674M | 0.9% | $12.52 | $7.40 | — | COM | 74019P108 |
| — | RIGEL PHARMACEUTICALS INC | 829,721 | $3.601M | 0.9% | $4.34 | $4.34 | — | COM NEW | 766559603 |
| ASGN | ASGN INC | 36,692 | $3.557M | 0.9% | $96.94 * | $78.37 | +30.4% | COM | 00191U102 |
| — | EUCRATES BIOMEDICAL ACQUISITION CORP. | 300,000 | $3.06M | 0.8% | $10.20 | $10.66 | — | UNIT 10/23/2027 | G3141W114 |
| MGNX | MACROGENICS INC | 112,587 | $3.024M | 0.8% | $26.86 * | $24.28 | +20.6% | COM | 556099109 |
| — | AEGLEA BIO THERAPEUTICS INC | 402,653 | $2.802M | 0.7% | $6.96 | $8.55 | — | COM | 00773J103 |
| — | CATALYST BIOSCIENCES INC | 623,892 | $2.701M | 0.7% | $4.33 | $7.85 | — | COM NEW | 14888D208 |
| PRQR | PROQR THERAPEUTICS NV | 380,045 | $2.562M | 0.6% | $6.74 * | $5.11 | +26.2% | SHS EURO | N71542109 |
| — | HEALTH SCIENCES ACQUISITIONS CORP 2 | 250,000 | $2.55M | 0.6% | $10.20 | $11.00 | — | ORD SHS | G4411D109 |
| AMN | AMN HEALTHCARE SERVICES INC | 26,001 | $2.522M | 0.6% | $97.00 * | $52.64 | +64.9% | COM | 001744101 |
| — | CYCLACEL PHARMACEUTICALS INC | 416,873 | $2.468M | 0.6% | $5.92 | $5.92 | — | COM | 23254L603 |
| — | CYMABAY THERAPEUTICS INC | 562,339 | $2.452M | 0.6% | $4.36 | $3.37 | — | COM | 23257D103 |
| TVTX | TRAVERE THERAPEUTICS INC | 150,000 | $2.189M | 0.5% | $14.59 * | $19.72 | 0.0% | COM | 89422G107 |
| — | FUSION PHARMACEUTICALS INC | 266,107 | $2.15M | 0.5% | $8.08 | $11.22 | — | COM | 36118A100 |
| — | MERSANA THERAPEUTICS INC | 157,259 | $2.136M | 0.5% | $13.58 | $15.50 | — | COM | 59045L106 |
| GOSS | GOSSAMER BIO INC | 261,400 | $2.123M | 0.5% | $8.12 * | $10.08 | -14.0% | COM | 38341P102 |
| — | CHARDAN HEALTHCARE ACQUISITION 2 CORP | 200,000 | $1.992M | 0.5% | $9.96 | $10.68 | — | COM | 15957T107 |
| CAH | CARDINAL HEALTH INC | 33,818 | $1.931M | 0.5% | $57.10 * | $46.44 | +12.4% | COM | 14149Y108 |
| — | VINCERX PHARMA INC | 140,913 | $1.83M | 0.5% | $12.99 | $18.89 | — | COM NEW | 92731L106 |
| — | SIERRA ONCOLOGY INC | 93,252 | $1.816M | 0.5% | $19.47 | $16.67 | — | COM NEW | 82640U404 |
| — | ARENA PHARMACEUTICALS INC | 21,738 | $1.483M | 0.4% | $68.22 | $47.41 | — | COM NEW | 040047607 |
| — | SALARIUS PHARMACEUTICALS INC | 1,354,291 | $1.436M | 0.4% | $1.06 | $1.18 | — | COM NEW | 79400X107 |
| — | MEI PHARMA INC | 426,047 | $1.214M | 0.3% | $2.85 | $3.06 | — | COM NEW | 55279B202 |
| — | ALPHA HEALTHCARE ACQUISITION CORP | 100,000 | $1.141M | 0.3% | $11.41 | $9.92 | — | UNIT 10/01/2023 | 020751202 |
| IDYA | IDEAYA BIOSCIENCES INC | 48,298 | $1.014M | 0.3% | $20.99 * | $7.88 | +160.8% | COM | 45166A102 |
| — | ATRECA INC | 113,455 | $967K | 0.2% | $8.52 | $15.06 | — | CL A COM | 04965G109 |
| FULC | FULCRUM THERAPEUTICS INC | 77,477 | $812K | 0.2% | $10.48 * | $11.55 | -12.5% | COM | 359616109 |
| — | LOGICBIO THERAPEUTICS INC | 182,630 | $811K | 0.2% | $4.44 | $4.44 | — | COM | 54142F102 |
| SEER | SEER INC | 23,775 | $779K | 0.2% | $32.77 * | $39.44 | 0.0% | COM CL A | 81578P106 |
| — | CAREMAX INC | 43,549 | $459K | 0.1% | $10.54 | $10.54 | — | COM CL A | 14171W103 |
| CVRX | CVRX INC | 15,000 | $420K | 0.1% | $28.00 | $28.00 | 0.0% | COM | 126638105 |
| — | MESOBLAST LTD | 54,800 | $410K | 0.1% | $7.48 | — | — | Put | 590717104 |
| — | NEOLEUKIN THERAPEUTICS INC | 38,312 | $354K | 0.1% | $9.24 | $12.32 | — | COM | 64049K104 |
| — | RUBIUS THERAPEUTICS INC | 6,200 | $151K | 0.0% | $24.35 | $26.51 | — | COM | 78116T103 |